1Tsagias N, Koliakos i, Karagiannis V, Eleftheriadou M, Koliakos GG. Isolation of mesenchymal stem ceils using the total length of umbilical cord for transplantation purposes, Transfus Med 2011; 21: 253-261.
3Gonzalez MA, Gonzalez-Rey E, Rico L, Buscher D, Delgado M. Adipose-derived mesenehymal stem cells alleviate experimental colitis by inhibiting inflammatory and autoimmune responses. Gastroenterology2009; 136: 978-989.
4Gonzalez MA, Gonzalez-Rey E, Rico L, Buscher D, Delgado M. Treatment of experimental arthritis by inducing immune tolerance with human adipose-derived mesenchymal stem cells. Arthritis Rheum 2009; 60: 1006-1019.
5Nemeth K, Leelahavanichkul A, Yuen PS, Mayer B, Parmelee A, Doi K etal. Bone marrow stromal cells attenuate sepsis vie prostaglandin E2-dependent reprogramming of host macrophages to increase their interleukin-lO production. Nat Med2009; 15: 4249.
6Kawada H, Fujita J, Kinjo K, Matsuzaki Y, Tsuma M, Miyatake H etal. Nonhematopoietic mesenchymal stem cells can be mobilized and differentiate into cardiomyocytes after myocardial infarction. Blood 2004; 104: 3581-3587.
7Wojakowski W, Tendera M. Mobilization of bone marrow-derived progenitor cells in acute coronary syndromes. Folia Histochem Cytobiol 2005, 43: 229-232.
8Chamberlain G, Fox J, Aehton B, Middleton J. Mesenchymal stem cells: their phenotype, differentiation capacity, immunological features and potential for homing. Stem Cells 2007; 25: 2739-2749.
9Dazzi F, Ramasamy R, Glennie S, Jones SP, Roberts I. The role of mesenchymal stem cells in haemopoiesis. Blood Rev2006; 20: 161-171.
10Schenk S, Mal N, Finan A, Zhang M, Kiedrowski M, Popovic Z et al. MCP-3 is a myocardial mesenchymal stem cell homing factor. Stern Cells 2007; 25:245-251.